Formulation and Evaluation of Extended-Release Bilayer Tablets Containing Empagliflozin and Metformin Hydrochloride for Diabetes Mellitus Management. Int. J. Pharm. Sci. Drug Res. [Internet]. 2024 Sep. 30 [cited 2025 Dec. 1];16(5):777-8. Available from: https://ijpsdronline.com/index.php/journal/article/view/9822